SCHEMBL12401852

SCHEMBL12401852

CC(C)(C)c1cc(Cl)c(CO)cc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.52
ALDH1A1 P00352 7/20 0.52
SMN1; SMN2 Q16637 6/20 0.52
CYP1A2 P05177 3/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 2/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
CYP2C9 P11712 6/20 0.47
TP53 P04637 5/20 0.47
CYP2C19 P33261 5/20 0.47
HIF1A Q16665 4/20 0.47
LMNA P02545 4/20 0.40
CYP3A4 P08684 3/20 0.40
HPGD P15428 2/20 0.40
ALOX12 P18054 1/20 0.40
TYR P14679 2/20 0.39
HTT P42858 2/20 0.39
NR1I2 O75469 1/20 0.39
MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16117993 0.85 ALOX15 (0.52) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16736921 0.81 ALOX15 (0.48) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL12401839 0.81 CYP2C9 (0.43) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16117670 0.79 ALDH1A1 (0.67) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16736743 0.79 ALOX15 (0.45) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL11007029 0.78 ALDH1A1 (0.65) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL11434411 0.78 ALDH1A1 (0.58) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16736702 0.77 ALOX15 (0.71) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL16117679 0.77 ALOX15 (0.52) ALOX15ALDH1A1SMN1; SMN2CYP1A2KDM4E
SCHEMBL12401842 0.77 HTR2A (0.50) ALOX15ALDH1A1SMN1; SMN2CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372873-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-02-12 US disclosed
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-28 US disclosed
US-7964624-B1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES PRSS1, SPINT2, PRSS2 ALOX15 3225/4885ALDH1A1 1255/4885SMN1; SMN2 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.